Form 4 · MDT
Medtronic director Kevin E. Lofton reports a other acquisition or disposition of 182 shares
Kevin E. Lofton, a Medtronic director, filed a Form 4 on Oct 21, 2026 at 5:18 PM ET reporting transactions on Oct 15, 2026.
The filing reports 182 shares in an other acquisition or disposition (code J).
After these transactions, the filing lists 9,977 shares of Ordinary Shares held directly.
Effect on holdings
Taken together, the rows reported here lowered Kevin E. Lofton's directly held shares by 1.8%, from 10,159 to 9,977.
Reporting person
- Kevin E. Lofton, director (as filed: Lofton Kevin E)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | J | Ordinary Shares | 182 | Disposed | 9,977 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Oct 21, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Medtronic company file → · More Medtronic filings
Disclosures
- Editor holdings in MDT
- The editor holds no position in Medtronic (MDT). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold MDT.